Analis | B Corp Certified’s Post

Time is Life when dealing with Sepsis. the SeptiCyte RAPID FDA cleared host-response, gene-expression PCR test can help clinicians and critical care RN's to make time sensitive decisions for suspected sepsis patients, in 60 min, on the molecular level. save ❤️💕💜! DM me to learn more. #septiCyteRAPID #infectionprevention #moleculartesting #PCR #hostresponse #patientcare #qualityimprovement #RN #Emergencymedicine #criticalcare #ICU

It’s sepsis awareness month! Throughout my over 20 year nursing career care has evolved from the ER to the ICU. Despite so many advances, we still haven’t slayed the sepsis dragon. 🐉 One thing that has not changed is a top concern for providers caring for septic patients…”is my patient PERFUSING?” Add using hemodynamic parameters to your critical care practice to manage sepsis & assess perfusion (it is in the guidelines 😋). We owe it to our patients to ensure they SURVIVE SEPSIS using every tool in our toolbox. 🧰 #sepsisawareness #hemodynamics #perfusion #cardiacoutputmonitoring #nurseeducator

Durable respiratory support as alternative to lung #transplantation for patients with chronic lung disease, review providing overview of recent advancements: 🫁 several ambulatory respiratory assist systems under development/preclinical investigation demonstrated favourable results + excellent biocompatibility & performance 🫁 currently, 2 ambulatory respiratory assist systems are clinically approved; early experiences have shown safety/efficacy, presenting viable alternative respiratory support strategy 🩸novel anticoagulation strategies under investigation to address artificial surface-induced thrombosis, minimizing bleeding risks ⚙️ innovative surface coatings are being explored to locally mitigate artificial surface-induced clot formation 🖇️ https://bit.ly/3WjI1Xo

🌍 Tackling the World's Leading Respiratory Threats with Innovation 💡 Did you know pneumonia is still the #1 infectious cause of death in children globally? And conditions like COVID-19 and Cystic Fibrosis continue to strain healthcare systems everywhere. Laboratorios Quimica Luar, are on a mission to change that. 🔬 An ibuprofen-based nebulized mist – a first-of-its-kind treatment that delivers medication directly to the lungs, offering a new, more effective solution for pediatric pneumonia, COVID-19, Cystic Fibrosis, and other complex respiratory conditions. 🌬️ Why is this a game-changer? - Direct lung delivery for faster, more targeted treatment 🚀 -A groundbreaking approach to treating conditions often left underserved 🌱 - A fresh, more accessible option for critical respiratory care #LaboratoriosQuimicaLuar #InnovationInHealthcare #RespiratoryTreatment #CysticFibrosis #COVID19Treatment #PneumoniaCare #MedTech #PharmaceuticalInnovation #IPStrategy #GlobalHealth #FutureOfMedicine

At bioMérieux, we drive awareness of #sepsis and the vital importance of early detection this Sept. 13 #WorldSepsisDay and every day. We know timing is critical when it comes to properly diagnosing and treating one of the primary causes of death around the world. With more than 49 million cases and more than 11 million deaths each year, sepsis poses a serious risk to patients and places a significant burden on healthcare systems globally. However, early detection and appropriate antibiotic treatments are available and essential to patient survival – reducing the likelihood of death or other adverse outcomes. In fact, as many as 80% of sepsis deaths could be prevented with rapid diagnosis and treatment. I am proud to be part of an organization that prioritizes improving lives through science, education, and partnerships. And when it comes to sepsis, bioMérieux is dedicated to delivering innovative diagnostic solutions that help clinicians obtain the time-critical information needed to support optimal patient management. This World Sepsis Day, join us in driving awareness of this global crisis and how we can improve prevention, diagnosis, and management of sepsis: https://rb.gy/gb3fi8 #WeArebioMérieux #PioneeringDiagnostics

No parent wants to hear a high-pitched whoop in their child’s cough. With the CDC reporting 5x more cases than last year, this season’s whooping cough (Bordetella pertussis) surge is alarming.  Clinical labs need solutions to quickly confirm the cause of respiratory infections in order to optimize patient care. Diasorin’s broad molecular portfolio of targeted and multiplexed respiratory assays can support your diagnostic stewardship goals by equipping your lab with the right panels to meet testing demand. Learn how we can help you address this season’s surge with confidence.  https://hubs.li/Q02-VlpN0 https://hubs.li/Q02-VhXy0 #WhoopingCough #RespiratoryHealth #LabTesting #PublicHealth #Bordetella #DiagnosticStewardship

Learn to diagnose and manage acute rheumatic fever with this comprehensive guide for junior doctors. Covering key history-taking questions, examination findings, investigations, and management strategies based on the latest evidence and guidelines." https://wix.to/FnfuuRW #newblogpost

MolecuLight is an essential tool for a more inclusive and equitable wound care practice. Our technology bridges the diagnostic gap in infection assessment between light and dark skin tones, while proudly improving bacterial detection by up to 12 times higher than standard clinical assessment.     As detailed in a newly published article by Charles Andersen and colleagues, signs of infection that would be readily detected on light skin tones are often missed during clinical examination of dark skin. This delays treatment, leaving time for infection to escalate resulting in poor outcomes.    By using MolecuLight to detect and remove infection-causing bacteria in a timely manner, you can help transform wound outcomes for patients in racial/ethnic minority groups.     Want to learn more? Pop a comment in the chat or send us a message and we’ll happily connect you with a MolecuLight representative.   #MolecuLight #HealthEquity #BridgeTheGap #HealthcareInnovation   #SkinSubstitutes #InfectionPrevention #CAMPS #CellularTissueProducts 

Are you aware of how much the WRONG antibiotics can harm a #UTI patient’s health? “𝘠𝘦𝘢𝘳𝘴 𝘰𝘧 𝘤𝘩𝘦𝘸𝘪𝘯𝘨 𝘥𝘰𝘸𝘯 𝘢𝘯𝘵𝘪𝘣𝘪𝘰𝘵𝘪𝘤𝘴 𝘵𝘩𝘢𝘵 𝘮𝘢𝘺 𝘰𝘳 𝘮𝘢𝘺 𝘯𝘰𝘵 𝘸𝘰𝘳𝘬 𝘩𝘢𝘴 𝘶𝘭𝘵𝘪𝘮𝘢𝘵𝘦𝘭𝘺 𝘥𝘦𝘴𝘵𝘳𝘰𝘺𝘦𝘥 𝘮𝘺 𝘣𝘰𝘥𝘺!” – Chronic UTI patient Giving the right antibiotic as quickly as possible improves patient outcomes – not only in terms of the time it takes for the symptoms to get better but also to prevent rare but significant complications like sepsis and hospital admissions! Sysmex Astrego’s PA-100 AST System – through an innovative diagnostic test – can identify the presence of a bacterial infection in just 15 minutes and accurately determine the right antibiotic to treat it within 45 minutes at the clinician’s office. Find more details about the PA-100 AST System: https://gtly.to/kks6Inmyq Thank you to ChallengeWorks for their support throughout our time on the Longitude Prize . #SysmexAstrego #PA100 #AMRfighter #UrinaryTractInfection

𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝐢𝐬 𝐒𝐞𝐩𝐬𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡: 𝐓𝐢𝐦𝐞 𝐭𝐨 𝐀𝐜𝐭 𝐚𝐧𝐝 𝐒𝐚𝐯𝐞 𝐋𝐢𝐯𝐞𝐬 🌍 Sepsis is a silent killer that impacts millions every year, often without people realizing the danger until it's too late. 💡 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐒𝐞𝐩𝐬𝐢𝐬: Sepsis is a life-threatening response to infection that can lead to tissue damage, organ failure, and death. It is responsible for 1 in 5 deaths globally, making it a critical public health issue. 🔍 𝐊𝐞𝐲 𝐅𝐚𝐜𝐭𝐬: - 47 to 50 million people are affected by Sepsis each year - Early detection and appropriate treatments are crucial to survival for Sepsis patients By understanding Sepsis and advocating for advanced diagnostic tools like Rapid Antimicrobial Susceptibility Testing solutions, we can make a real difference in patient care. For more resources, visit the Sepsis Alliance & Global Sepsis Alliance #SepsisAwarenessMonth #Sepsis #Healthcare #RapidAST #AntibioticStewardship #PatientSafety #SaveLives